U.S. federal agency safeguarding food, drug, and medical product safety
The Fauci diaries have intensified scrutiny of his handling of the COVID-19 pandemic. A Senate panel has voted to hold him in contempt for refusing to answer questions, while states push for records. Republicans argue for accountability; Democrats defend the former NIH director amid a renewed focus on origins, lockdowns, and media coverage.
President Trump has signed an executive order directing federal health officials to cut the federal recommended childhood vaccine list, to split the combined MMR vaccine into separate measles, mumps and rubella doses once single‑disease products are available, and to space routine immunisations across separate medical visits. Public health groups and drugmakers have said the changes lack scientific support and will increase missed vaccinations during a major U.S. measles outbreak.
Nvidia has enlisted six Wall Street firms to finance a $500 billion buildout of AI infrastructure, treating compute as a new asset class. The plan centers on financing data centers and GPU clusters for customers unable to pay upfront, with OpenAI-related projects and neoclouds in focus. Executives cite long-term value and revenue generation, while cautions focus on depreciation risk and China’s potential price competition.
The White House has issued an executive order reducing federal vaccine recommendations to 11 core shots and urging the separation of the MMR vaccine into three injections. Physicians warn the move risks confusion and slower protection, while public health groups stress that CDC guidance remains unchanged and vaccines should proceed as recommended.
The U.S. CPSC warns that certain 10-liter and 15-liter Cooluli minifridges sold online since 2019 have an internal power switch that can short circuit, risking fire and burns. Reports exceed $80,000 in property damage and one smoke-inhalation injury has been reported. Cooluli offers a free repair kit and replacement power cord for affected units.
The newly released texts show Fauci discussing early vaccination risks in pregnancy, while officials acknowledge uncertainty in 2021. Since then, large studies have found no link between COVID-19 vaccines and miscarriage or adverse pregnancy outcomes. The conversation has become a political flashpoint as Republican lawmakers push into the public sphere.
Federal prosecutors have narrowed their case against Jonathan Rinderknecht to two charges related to fires that destroyed thousands of structures in Malibu's Pacific Palisades. A mistrial was declared in June after jurors deadlocked on three counts. A retrial is scheduled for fall.
A wave of research shows AI boosts job-market efficiency while blurring lines between genuine experience and AI-assisted claims. LinkedIn edits after leaving roles have surged since ChatGPT’s rise, with nearly 1 in 5 profiles retroactively adding AI skills. Employers report longer hiring cycles and rising candidate skepticism, while younger workers face AI-driven disruption in entry-level jobs.
The DRC has recorded the largest-ever Bundibugyo Ebola outbreak, with more than 5,600 confirmed cases and over 2,700 deaths, and international agencies are racing to respond. WHO and partners have allocated 70,000 Ervebo doses—20,000 for a Phase III trial and 50,000 for frontline workers—while CEPI has awarded up to $16.5m to advance a Minapharm Bundibugyo vaccine into early human trials. Uganda has received MBP134 antibody vials as a precautionary measure.
UK health agencies say salmonella infections may be linked to eggs imported from outside the UK. One fatality has been confirmed. Public health guidance urges vulnerable groups to avoid under‑cooked eggs, while well‑cooked eggs remain safe. The outbreak has affected England most, with hundreds of cases across the UK.
The Kennedy Center is embroiled in a legal fight over whether President Donald J. Trump’s name can be inscribed on the building. A court hearing is set as Beatty argues the move violates the Kennedy Center statute and risks the center’s finances. Trustees insist the changes are essential to fundraising and reopening after modifications.
A MAHA-backed letter to Trump, Kennedy and cabinet officials has voiced health-first concerns about coal-powered data centers and urged a shift toward solar, geothermal, and efficiency. The move signals growing friction between MAHA activists and the administration as data centers draw increasing scrutiny.
A multi-state outbreak tied to alfalfa sprouts has infected at least 55 people nationwide, including four hospitalizations. Cases are linked to Minnesota grower Everything Sprouts and its Calco and Everything Sprouts brands. FDA and CDC are coordinating testing and monitoring, with recalls and safety reviews ongoing.
A review of mobility and balance assessments shows they indicate functional health and fall risk, not life expectancy. Tests like sit-to-stand and Timed Up and Go help identify weaknesses and guide care, while researchers note variability across populations.
New observational data suggests Shingrix vaccination in older adults is associated with lower cardiovascular risk and reduced dementia incidence over multi-year follow-ups. Studies compare Shingrix to Zostavax and find reductions in heart disease, stroke, and dementia, with stronger signals in men for heart outcomes.
The FDA has approved daraxonrasib (Rasonque), a once-daily pill from Revolution Medicines, for adults with metastatic pancreatic cancer who have received prior therapy or cannot take combination chemotherapy. A 500‑patient trial has shown median survival of 13.2 months versus 6.7 months for chemotherapy; a 30‑day supply will cost about $39,800 and expanded access has already treated thousands.
General Mills has shifted to natural colorings derived from fruits, vegetables and spices in most U.S. cereals. About 90% of U.S. retail products are now free of artificial dyes, with remaining items set to convert by end-2027. Kellogg has followed suit, and other major brands have pledged to remove synthetic dyes amid regulatory and consumer pressure.
Multiple recalls are rippling through the US food system. A donut recall in March labeling issues, several wraps tied to STEC, and a broad recall wave linked to peppers and berries highlight ongoing safety concerns. Authorities urge discard or return of affected items and emphasize consumer safety as top priority.
The FDA, CDC and state health officials have identified more cases of cyclosporiasis in Georgia, Tennessee and Texas, bringing the national tally to 11,458. Investigators continue examining iceberg lettuce from a Taylor Farms facility in central Mexico, with officials insisting recalled product is off the market. The illness, cyclosporiasis, has prompted ongoing surveillance as outbreaks peak in warm months.
Major U.S. medical societies have published coordinated guidance for flu, COVID-19 and RSV vaccinations after the FDA approved updated COVID and flu shots. The American Medical Association and partner groups have compiled evidence and tailored recommendations for age and risk groups while the CDC advisory process remains delayed by political and legal disputes. Enhanced and mRNA flu options are available for older adults.
The Corte Madera Town Council votes to advance an ordinance banning tobacco and nicotine products, including vapes, with a transition through Jan. 31, 2027. Residents may keep possessions. Public comment highlighted concerns from students and families affected by tobacco-related illness.
GLP-1 medications are being increasingly prescribed off-label to children aged 8–11 in the US, despite no FDA approval for under-12s. A NYU Langone study shows a dramatic rise in June 2026, while experts warn about long-term effects and the broader obesity crisis.
This week has seen several medical research and regulatory developments. Insilico Medicine has reported that its experimental drug rentosertib changed blood‑protein patterns that aging clocks read as three to four years younger in a small trial. Stanford teams have published studies showing they can grow hindbrain neurons separately and implant human cortical organoids into mice. The US health department has appointed permanent directors for three FDA centers.
Several women in Africa and the UK face long waits for fibroid treatment and endometriosis diagnosis, highlighting delays in access to care, testing, and surgical options. New tests abroad offer hope, but are not yet widely available in the US.
The US Centers for Disease Control and Prevention has declared the multistate cyclospora outbreak tied to iceberg lettuce over after cases have fallen sharply. Federal investigators have linked the outbreak to iceberg lettuce imported from central Mexico by Taylor Farms; about 12,800 people were infected, 570 were hospitalised and two people died.
A synthesis of recent sleep studies shows wearables may misjudge sleep quality, narcolepsy treatment advances gain regulatory traction, and weekend catch-up sleep ties to lower hypertension risk, prompting a nuanced view of how to monitor and improve sleep.
Flu vaccines are underway and updated COVID-19 shots are arriving nationwide after FDA approval. RSV remains a threat, prompting guidance from medical societies as Trump health officials rethink autumn vaccine policies. An advisory panel remains in a legal dispute, while doctors push clear, science-based guidance. Older adults and high-risk groups are urged to vaccinate, with a new mRNA flu shot showing improved effectiveness.
McKenna West has filed an emergency appeal seeking to halt a California court order that recognizes California couple Omar Ahmed and Nausheen Gilkar as the parents of a seriously ill infant. The child, born with hypoplastic left heart syndrome, has undergone surgery. West argues the couple would withhold life-saving care; the Supreme Court’s involvement remains uncertain.
The FDA has cleared four blood tests to help diagnose Alzheimer's in people with memory problems, a move that could speed access to therapies. Experts caution that tests are not for asymptomatic individuals, and many questions remain about accuracy. Readers are advised to focus on brain-healthy risks like blood pressure, diabetes and smoking.
The Trump administration has announced a plan to align U.S. Medicaid drug prices with those in other wealthy nations, a move touted as saving billions over a decade. The administration says MFN-style deals with drugmakers will reduce spending and expand access, while critics question the transparency and long-term sustainability.
The Justice Department has reached a settlement with Abbott over the Sturgis, Michigan plant that produced a major share of U.S. infant formula. The settlement addresses unsanitary conditions and recalls tied to Cronobacter sakazakii, while Abbott maintains no admission of fault. Regulators say the plant’s issues contributed to a nationwide shortage.
Saphier has been nominated to serve as surgeon general. She is navigating questions about vaccine policy, credentials, and potential conflicts of interest as lawmakers scrutinize her readiness to lead public health messaging.
The Supreme Court has put on hold a lower‑court order that required migrants facing removal to third countries receive notice and a meaningful chance to raise fear‑of‑persecution claims. The court has granted the administration’s emergency request, will hear arguments in December, and three liberal justices have dissented.
Novo has laid out a plan to diversify beyond Wegovy and Ozempic as it faces looming exclusivity losses. Capital Markets Day signals a push into cardiovascular, liver and blood disorders with a target to expand its pipeline, while investors question credibility and near-term milestones amid a evolving GLP-1 landscape dominated by Lilly.
Influencer Braden Peters, known online as Clavicular, has been charged in Massachusetts with rape, providing liquor to a minor, and drugging for sexual intercourse, linked to an alleged May 2025 incident on Cape Cod. A separate Florida civil suit accuses him of coercion and non-consensual procedures. Peters denies the accusations and faces further legal proceedings.
Two Ole Miss students have died in separate locations. Authorities say kratom was found at the scenes, but there is no confirmed information that kratom contributed to either death. Investigations are ongoing; toxicology reports are being expedited.
New lawsuits claim GLP-1 diabetes drugs may cause nonarteritic anterior ischemic optic neuropathy (NAION), a rare but serious eye condition. Regulators are reviewing evidence, while manufacturers dispute the claims. Reports cite studies showing mixed results on risk, with the absolute risk remaining very low.
The Speaker is campaigning across multiple states to defend Republican-held seats while pursuing a broader message on cost of living and reform. The push follows a six-week sprint across 20 states, with a focus on key battlegrounds as November nears.
A recall first issued in July has expanded to include more frozen berry products tied to an E. coli outbreak that has infected at least 17 people across Florida and Georgia. The FDA warns consumers to discard affected products and seek refunds. Public health officials say the outbreak, now linked to Frutas y Hortalizas del Sur S.A., has prompted recalls across retailers including Walmart and Trader Joe’s.
The FDA has closed its investigation into the Taylor Farms cyclospora outbreak linked to lettuce. Investigators found cyclospora in a wastewater tank and a drainage ditch at the Taylor Farms site in Guanajuato, Mexico, but the agency says it is unclear how contamination occurred. The outbreak had caused nearly 13,000 illnesses across the United States.
The Supreme Court is considering whether federal law preempts state climate liability suits against ExxonMobil and Suncor, a Boulder, Colorado case that could limit local claims seeking damages for climate-related costs. Justices are weighing jurisdiction and federal preemption as the term opens, with the outcome potentially affecting dozens of similar cases.
PepsiCo has initiated a class II recall after undeclared Yellow No. 5 and/or No. 6 dyes were found in several Gatorade flavors. The recall covers 28-ounce bottles distributed across 37 states. Consumers are advised not to drink affected products and to seek refunds; the FDA classifies the risk as mid-level.
A federal lawsuit in Seattle accuses Starbucks of labeling eight protein drinks as sugar-free while containing 13–21 grams of sugar per venti, prompting questions about added vs. total sugar and FDA labeling rules. Starbucks denies wrongdoing and says the sugar comes from lactose in milk.